Physician Assistant Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Camila Benatar Pineda

Physician Assistant Hialeah, FL Physician Assistant

NPI 1639703440 CMS profile 11300831

2140 W 68Th St Ste 200, Hialeah, FL 33016

Open in the dashboard

General payments

$5,476

224 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Camila Benatar Pineda of Hialeah, FL is reported in the CMS Open Payments database as having received $5,476 across 224 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 92nd percentile of Physician Assistant profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,056 47
2024 General $775 35
2023 General $927 50
2022 General $2,301 80
2021 General $417 12

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Camila Benatar Pineda
  • Physician Assistant median
  • Middle half of Physician Assistant
  • National median

In program year 2025, general payments to Camila Benatar Pineda were reported at $1,056. Among 68,903 Physician Assistant profiles paid that year, the median was $184 and the middle half received between $57 and $620.

Show as a table
Year Camila Benatar Pineda Physician Assistant median Middle half National median
2019 $0 $34 $17–$122 $163
2020 $0 $33 $16–$78 $114
2021 $417 $132 $37–$438 $132
2022 $2,301 $155 $48–$522 $149
2023 $927 $167 $52–$557 $160
2024 $775 $178 $55–$600 $164
2025 $1,056 $184 $57–$620 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. Axonics Modulation Technologies, Inc. $939 12 payments
  2. Astellas Pharma US Inc $576 29 payments
  3. Pfizer Inc. $551 31 payments
  4. Sumitomo Pharma America, Inc. $535 34 payments
  5. Janssen Biotech, Inc. $514 12 payments
  6. TOLMAR Pharmaceuticals, Inc. $385 14 payments
  7. Urovant Sciences Inc $320 21 payments
  8. Medtronic, Inc. $251 3 payments
  9. Bayer HealthCare Pharmaceuticals Inc. $228 12 payments
  10. AbbVie, Inc. $192 10 payments
  11. Other $986 46 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Food and Beverage $4,623 217 payments
  2. Travel and Lodging $568 4 payments
  3. Education $285 3 payments
Products named General payments · program years 2021–2025
  1. Axonics $939 12 payments
  2. GEMTESA $854 55 payments
  3. XTANDI $704 37 payments
  4. ERLEADA $548 13 payments
  5. ORGOVYX $529 30 payments
  6. ELIGARD $467 18 payments
  7. MYRBETRIQ $300 21 payments
  8. INTERSTIM $251 3 payments
  9. Nubeqa $228 12 payments
  10. LUPRON DEPOT $192 10 payments
  11. Other $1,571 77 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

224 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Physician Assistant in Florida

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record